Literature DB >> 7788967

'Lewy body disease': clinico-pathological correlations in 18 consecutive cases of Parkinson's disease with and without dementia.

R A de Vos1, E N Jansen, F C Stam, R Ravid, D F Swaab.   

Abstract

One of the characteristic histological features of Parkinson's disease (PD), with or without dementia, is the presence of Lewy bodies (LBs) in the brainstem and neocortical and limbic structures. They are often accompanied by Alzheimer type pathology (ATP). In the present retrospective study the clinical features and post-mortem findings of 18 consecutive and unselected PD patients were compared, with special reference to the frequent but not exclusive association of LBs with ATP in Lewy body disease (LBD). LBD is the term applied to a particular pattern of neuronal degeneration associated with LBs. In this study of idiopathic PD patients ATP seems to be the major determinant of the cognitive decline in most patients. Cortical Lewy Bodies (CLBs) were present in all patients reviewed, whether or not dementia was present. It was not possible to distinguish a specific pattern in the cognitive or psychopathological symptoms of dementia that would differentiate LBD from Alzheimer's disease (AD). Although in most cases hippocampal CA2-3 ubiquitin immunoreactive neurites were observed, here again there was no correlation with the presence of dementia.

Entities:  

Mesh:

Year:  1995        PMID: 7788967     DOI: 10.1016/0303-8467(94)00060-j

Source DB:  PubMed          Journal:  Clin Neurol Neurosurg        ISSN: 0303-8467            Impact factor:   1.876


  8 in total

1.  Autonomic nervous system testing may not distinguish multiple system atrophy from Parkinson's disease.

Authors:  D E Riley; T C Chelimsky
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-01       Impact factor: 10.154

2.  Longitudinal evaluation of cerebral morphological changes in Parkinson's disease with and without dementia.

Authors:  Blanca Ramírez-Ruiz; María José Martí; Eduardo Tolosa; David Bartrés-Faz; Chistopher Summerfield; Pilar Salgado-Pineda; Beatriz Gómez-Ansón; Carme Junqué
Journal:  J Neurol       Date:  2005-07-05       Impact factor: 4.849

Review 3.  Pattern of brain destruction in Parkinson's and Alzheimer's diseases.

Authors:  H Braak; E Braak; D Yilmazer; R A de Vos; E N Jansen; J Bohl
Journal:  J Neural Transm (Vienna)       Date:  1996       Impact factor: 3.575

Review 4.  Epidemiology of the dementias: recent developments and new approaches.

Authors:  C M van Duijn
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-05       Impact factor: 10.154

5.  Plasma thiamine deficiency associated with Alzheimer's disease but not Parkinson's disease.

Authors:  M Gold; R A Hauser; M F Chen
Journal:  Metab Brain Dis       Date:  1998-03       Impact factor: 3.584

6.  Lewy body cortical involvement may not always predict dementia in Parkinson's disease.

Authors:  C Colosimo; A J Hughes; L Kilford; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-07       Impact factor: 10.154

7.  The Levodopa Response Varies in Pathologically Confirmed Parkinson's Disease: A Systematic Review.

Authors:  Vanessa Pitz; Naveed Malek; Edward S Tobias; Katherine A Grosset; Steve Gentleman; Donald G Grosset
Journal:  Mov Disord Clin Pract       Date:  2020-01-07

8.  Changes of brain gray matter structure in Parkinson's disease patients with dementia.

Authors:  Jianguo Xia; Jinlin Miu; Hongbin Ding; Xiuping Wang; Hua Chen; Juan Wang; Juan Wu; Jingli Zhao; Huanxin Huang; Weizhong Tian
Journal:  Neural Regen Res       Date:  2013-05-15       Impact factor: 5.135

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.